Symmetry Medical, Inc. (SMA) Tops Q1 EPS by 2c; Reaffirms

Symmetry Medical, Inc. (NYSE: SMA) reported Q1 EPS of $0.09, $0.02 better than the analyst estimate of $0.07. Revenue for the quarter came in at $100.7 million versus the consensus estimate of $98.77 million.

Symmetry Medical, Inc. reaffirmed FY2012 guidance.

For earnings history and earnings-related data on Symmetry Medical, Inc. (SMA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• SelectQuote, Inc. (SLQT) Misses Q4 EPS by 4c ; Offers Guidance
• Raymond James upgrades AMD, sees $201 billion server CPU market by 2030
• The Marzetti Company (MZTI) Tops Q2 EPS by 6c